Commonwealth Retirement Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Commonwealth Retirement Investments's BMY Position: Q1 2026 in Review
Commonwealth Retirement Investments increased its Bristol-Myers Squibb (BMY) stake by 6.3% in Q1 2026, buying an estimated $248K and bringing the position to 72,135 shares worth $4.37M. The position accounts for 1.35% of the portfolio, ranked #21.
Commonwealth Retirement Investments first reported a position in BMY in Q2 2024 and has held it in 8 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Commonwealth Retirement Investments held 72,135 shares of Bristol-Myers Squibb worth $4.37M as of Q1 2026.
- Commonwealth Retirement Investments bought 4,253 Bristol-Myers Squibb shares in Q1 2026, an estimated $248K.
- Bristol-Myers Squibb made up 1.35% of Commonwealth Retirement Investments's portfolio in Q1 2026, its #21 holding.
- Commonwealth Retirement Investments first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 8 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Commonwealth Retirement Investments's 13F filing for Q1 2026, filed 11 May 2026.